FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Cho, Steve Y., Huff, Daniel T., Jeraj, Robert, Albertini, Mark R.
Published in Seminars in nuclear medicine (01.11.2020)
Published in Seminars in nuclear medicine (01.11.2020)
Get full text
Journal Article
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609
Tarhini, Ahmad A, Lee, Sandra J, Hodi, F Stephen, Rao, Uma N M, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriett M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy
Pozorski, Vincent, Park, Yeonhee, Mohamoud, Yusuf, Tesfamichael, Dahlia, Emamekhoo, Hamid, Birbrair, Alexander, Albertini, Mark R., Ma, Vincent T.
Published in Pigment cell and melanoma research (01.11.2023)
Published in Pigment cell and melanoma research (01.11.2023)
Get full text
Journal Article
Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
SHUSTERMAN, Suzanne, LONDON, Wendy B, GAN, Jacek, EICKHOFF, Jens, DESANTES, Kenneth B, COHN, Susan L, HECHT, Toby, GADBAW, Brian, REISFELD, Ralph A, MARIS, John M, SONDEL, Paul M, GILLIES, Stephen D, HANK, Jacquelyn A, VOSS, Stephan D, SEEGER, Robert C, REYNOLDS, C. Patrick, KIMBALL, Jennifer, ALBERTINI, Mark R, WAGNER, Barrett
Published in Journal of clinical oncology (20.11.2010)
Published in Journal of clinical oncology (20.11.2010)
Get full text
Journal Article
Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithm
Santoro-Fernandes, Victor, Huff, Daniel, Scarpelli, Mathew L, Perk, Timothy G, Albertini, Mark R, Perlman, Scott, Yip, Stephen S F, Jeraj, Robert
Published in Physics in medicine & biology (07.08.2021)
Published in Physics in medicine & biology (07.08.2021)
Get full text
Journal Article
Development of a next-generation sequencing protocol for the canine T cell receptor beta chain repertoire
Zuleger, Cindy L, Schwartz, Rene Welch, Ong, Irene M, Newton, Michael A, Vail, David M, Albertini, Mark R
Published in Veterinary immunology and immunopathology (01.02.2024)
Published in Veterinary immunology and immunopathology (01.02.2024)
Get full text
Journal Article
Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells
Kaitz, Noah A., Zuleger, Cindy L., Yu, Peng, Newton, Michael A., Albertini, Richard J., Albertini, Mark R.
Published in Mutation research. Reviews in mutation research (01.01.2022)
Published in Mutation research. Reviews in mutation research (01.01.2022)
Get full text
Journal Article
NK cells propagate T cell immunity following in situ tumor vaccination
Jin, Won Jong, Jagodinsky, Justin C., Vera, Jessica M., Clark, Paul A., Zuleger, Cindy L., Erbe, Amy K., Ong, Irene M., Le, Trang, Tetreault, Kaitlin, Berg, Tracy, Rakhmilevich, Alexander L., Kim, KyungMann, Newton, Michael A., Albertini, Mark R., Sondel, Paul M., Morris, Zachary S.
Published in Cell reports (Cambridge) (26.12.2023)
Published in Cell reports (Cambridge) (26.12.2023)
Get full text
Journal Article
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma
Albertini, Mark R, Zuleger, Cindy L, Ranheim, Erik A, Shiyanbola, Oyewale, Sondel, Paul M, Morris, Zachary S, Eickhoff, Jens, Newton, Michael A, Ong, Irene M, Schwartz, Rene Welch, Hayim, Rubi, Kurzman, Ilene D, Turek, Michelle, Vail, David M
Published in Melanoma research (01.08.2024)
Published in Melanoma research (01.08.2024)
Get more information
Journal Article
Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2
Yang, Richard K, Kuznetsov, Igor B, Ranheim, Erik A, Wei, Jun S, Sindiri, Sivasish, Gryder, Berkley E, Gangalapudi, Vineela, Song, Young K, Patel, Viharkumar, Hank, Jacquelyn A, Zuleger, Cindy, Erbe, Amy K, Morris, Zachary S, Quale, Renae, Kim, KyungMann, Albertini, Mark R, Khan, Javed, Sondel, Paul M
Published in Clinical cancer research (01.07.2020)
Published in Clinical cancer research (01.07.2020)
Get full text
Journal Article
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
Albertini, Mark R., Yang, Richard K., Ranheim, Erik A., Hank, Jacquelyn A., Zuleger, Cindy L., Weber, Sharon, Neuman, Heather, Hartig, Greg, Weigel, Tracey, Mahvi, David, Henry, Mary Beth, Quale, Renae, McFarland, Thomas, Gan, Jacek, Carmichael, Lakeesha, Kim, KyungMann, Loibner, Hans, Gillies, Stephen D., Sondel, Paul M.
Published in Cancer Immunology, Immunotherapy (01.10.2018)
Published in Cancer Immunology, Immunotherapy (01.10.2018)
Get full text
Journal Article
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)
Agarwala, Sanjiv S, Lee, Sandra J, Yip, Waiki, Rao, Uma N, Tarhini, Ahmad A, Cohen, Gary I, Reintgen, Douglas S, Evans, Terry L, Brell, Joanna M, Albertini, Mark R, Atkins, Michael B, Dakhil, Shaker R, Conry, Robert M, Sosman, Jeffrey A, Flaherty, Lawrence E, Sondak, Vernon K, Carson, William E, Smylie, Michael G, Pappo, Alberto S, Kefford, Richard F, Kirkwood, John M
Published in Journal of clinical oncology (10.03.2017)
Published in Journal of clinical oncology (10.03.2017)
Get full text
Journal Article
MAGE-C2 Promotes Growth and Tumorigenicity of Melanoma Cells, Phosphorylation of KAP1, and DNA Damage Repair
Bhatia, Neehar, Xiao, Tony Z., Rosenthal, Kimberly A., Siddiqui, Imtiaz A., Thiyagarajan, Saravanan, Smart, Brendan, Meng, Qiao, Zuleger, Cindy L., Mukhtar, Hasan, Kenney, Shannon C., Albertini, Mark R., Jack Longley, B.
Published in Journal of investigative dermatology (01.03.2013)
Published in Journal of investigative dermatology (01.03.2013)
Get full text
Journal Article
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
Albertini, Mark R., Hank, Jacquelyn A., Gadbaw, Brian, Kostlevy, Jordan, Haldeman, Jennifer, Schalch, Heidi, Gan, Jacek, Kim, KyungMann, Eickhoff, Jens, Gillies, Stephen D., Sondel, Paul M.
Published in Cancer Immunology, Immunotherapy (01.12.2012)
Published in Cancer Immunology, Immunotherapy (01.12.2012)
Get full text
Journal Article
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
Bhardwaj, Nina, Friedlander, Philip A, Pavlick, Anna C, Ernstoff, Marc S, Gastman, Brian R, Hanks, Brent A, Curti, Brendan D, Albertini, Mark R, Luke, Jason J, Blazquez, Ana B, Balan, Sreekumar, Bedognetti, Davide, Beechem, Joseph M, Crocker, Andrea S, D'Amico, Leonard, Danaher, Patrick, Davis, Thomas A, Hawthorne, Thomas, Hess, Bruce W, Keler, Tibor, Lundgren, Lisa, Morishima, Chihiro, Ramchurren, Nirasha, Rinchai, Darawan, Salazar, Andres M, Salim, Bob A, Sharon, Elad, Vitale, Laura A, Wang, Ena, Warren, Sarah, Yellin, Michael J, Disis, Mary L, Cheever, Martin A, Fling, Steven P
Published in Nature cancer (01.12.2020)
Published in Nature cancer (01.12.2020)
Get more information
Journal Article
A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel
Flaherty, Keith T, Schiller, Joan, Schuchter, Lynn M, Liu, Glenn, Tuveson, David A, Redlinger, Maryann, Lathia, Chetan, Xia, Chenghua, Petrenciuc, Oana, Hingorani, Sunil R, Jacobetz, Michael A, Van Belle, Patricia A, Elder, David, Brose, Marcia S, Weber, Barbara L, Albertini, Mark R, O'Dwyer, Peter J
Published in Clinical cancer research (01.08.2008)
Published in Clinical cancer research (01.08.2008)
Get full text
Journal Article
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma
Tarhini, Ahmad A, Lee, Sandra J, Li, Xiaoxue, Rao, Uma N M, Nagarajan, Arun, Albertini, Mark R, Mitchell, Jr, Jerry W, Wong, Stuart J, Taylor, Mark A, Laudi, Noel, Truong, Phu V, Conry, Robert M, Kirkwood, John M
Published in Clinical cancer research (15.01.2019)
Published in Clinical cancer research (15.01.2019)
Get full text
Journal Article